tradingkey.logo
tradingkey.logo
Search

Design Therapeutics Inc

DSGN
Add to Watchlist
12.180USD
-0.440-3.49%
Close 07-31 16:00ETQuotes delayed by 15 min
760.73MMarket Cap
LossP/E TTM

DSGN Financials

See Design Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Design Therapeutics Inc Earnings Date

Latest Release
Apr 28, 2026
EPS / Forecast
-0.29/-0.33
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.22
-38.92%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
8.03%-0.29
-13.06%-0.27
-29.60%-0.30
-60.95%-0.34
-58.77%-0.31
-14.07%-0.24
18.34%-0.23
41.48%-0.21
43.03%-0.20
31.98%-0.21
---0.28
---0.36
---0.35
---0.31
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
Net Profit
0.45%-17.64M
-17.19%-16.00M
-30.36%-17.00M
-61.82%-19.08M
-59.52%-17.71M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-56.71%-17.34M
-56.42%-17.70M
-96.42%-15.00M
-140.57%-13.27M
---11.06M
---11.32M
-429.54%-7.64M
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
Operating profit
3.49%-19.71M
-8.84%-18.17M
-18.87%-19.31M
-43.38%-21.57M
-41.79%-20.42M
-10.40%-16.69M
13.69%-16.25M
33.43%-15.04M
33.49%-14.40M
22.02%-15.12M
1.93%-18.82M
-44.48%-22.60M
-61.94%-21.65M
-74.28%-19.39M
-69.29%-19.19M
-103.45%-15.64M
-135.39%-13.37M
---11.13M
---11.34M
-425.43%-7.69M
Net Profit
0.45%-17.64M
-17.19%-16.00M
-30.36%-17.00M
-61.82%-19.08M
-59.52%-17.71M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-56.71%-17.34M
-56.42%-17.70M
-96.42%-15.00M
-140.57%-13.27M
---11.06M
---11.32M
-429.54%-7.64M
Current assets
-2.82%227.05M
-9.78%223.78M
-18.74%209.03M
-17.01%219.79M
-14.69%233.64M
-12.84%248.04M
-12.66%257.24M
-13.46%264.84M
-14.13%273.89M
-15.08%284.58M
-15.48%294.54M
-15.39%306.05M
-14.69%318.94M
-13.05%335.12M
-11.84%348.49M
-10.66%361.72M
-9.20%373.87M
--385.44M
--395.29M
--404.88M
Total current liabilities
23.73%10.19M
54.28%13.05M
50.34%11.17M
36.80%8.75M
16.10%8.24M
-12.06%8.46M
-40.02%7.43M
-47.30%6.39M
-21.59%7.09M
-10.71%9.62M
19.00%12.39M
64.23%12.13M
65.09%9.05M
103.98%10.78M
89.14%10.41M
116.98%7.39M
47.87%5.48M
--5.28M
--5.50M
--3.41M
Total assets
-2.96%230.44M
-10.27%226.20M
-19.06%211.77M
-17.32%222.89M
-14.82%237.47M
-12.96%252.09M
-12.75%261.63M
-13.49%269.58M
-14.15%278.79M
-15.09%289.64M
-15.43%299.87M
-15.30%311.63M
-14.27%324.74M
-12.65%341.14M
-11.44%354.57M
-9.19%367.93M
-8.03%378.80M
--390.56M
--400.35M
--405.15M
Total liabilities
29.64%12.39M
37.05%13.70M
31.32%12.05M
18.09%9.85M
3.46%9.56M
-16.39%10.00M
-38.47%9.18M
-43.78%8.34M
-22.55%9.24M
-13.53%11.96M
9.40%14.91M
37.76%14.84M
40.43%11.93M
64.08%13.83M
55.09%13.63M
203.78%10.77M
120.69%8.49M
--8.43M
--8.79M
--3.54M
Total equity
-4.33%218.05M
-12.22%212.50M
-20.89%199.72M
-18.45%213.04M
-15.45%227.92M
-12.82%242.10M
-11.41%252.45M
-11.98%261.24M
-13.83%269.56M
-15.16%277.69M
-16.42%284.96M
-16.90%296.80M
-15.53%312.82M
-14.35%327.31M
-12.93%340.94M
-11.07%357.16M
-9.24%370.31M
--382.13M
--391.56M
--401.60M
Net operating income
2.13%-16.43M
-21.36%-11.97M
-16.93%-11.16M
-28.25%-14.44M
-34.97%-16.79M
22.96%-9.86M
34.32%-9.55M
18.43%-11.26M
28.61%-12.44M
15.19%-12.80M
-4.57%-14.53M
-31.47%-13.80M
-47.32%-17.42M
-63.55%-15.09M
-70.25%-13.90M
-26.67%-10.50M
-219.91%-11.83M
---9.23M
---8.16M
---8.29M
Net investment
-196.43%-7.59M
-732.26%-11.58M
211.74%6.51M
-26.40%20.12M
-61.83%7.87M
-67.02%1.83M
-138.16%-5.83M
128.12%27.33M
4.47%20.62M
626.04%5.55M
124.08%15.27M
107.63%11.98M
4666.43%19.73M
97.89%-1.06M
-1157.22%-63.39M
-627.63%-156.96M
-98.20%414.00K
---50.06M
---5.04M
---21.57M
Net financing
86569.57%19.93M
9526.24%25.32M
3600.00%37.00K
57.64%361.00K
15.00%23.00K
-47.50%263.00K
-92.31%1.00K
9.05%229.00K
--20.00K
285.38%501.00K
-91.39%13.00K
203.96%210.00K
-100.00%0.00
-32.64%130.00K
403.33%151.00K
-4140.00%-202.00K
-99.96%156.00K
--193.00K
--30.00K
--5.00K

FAQs

What are the current assets of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its current assets were 223.78M, with a year-on-year change of -9.78.

What are the total assets of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its total assets of Design Therapeutics Inc were 226.20M, with a year-on-year change of -10.27.

What are the total liabilities of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its total liabilities of Design Therapeutics Inc were 13.70M, with a year-on-year change of 37.05.

What is the total equity of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its total equity of Design Therapeutics Inc was 212.50M, with a year-on-year change of -12.22.

What is the net operating income of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its net operating income of Design Therapeutics Inc was -79.47M, with a year-on-year change of -27.39.

What is the net investment of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its net investment of Design Therapeutics Inc was 22.91M, with a year-on-year change of -47.87.

What is the net financing of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its net financing of Design Therapeutics Inc was 25.74M, with a year-on-year change of 4917.15.

What is the Earnings Per Share (EPS) of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.22, with a year-on-year change of -38.92.

What is the net income of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its net income was -69.79M, with a year-on-year change of -40.74.

What is the Return on Equity (ROE) of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -30.70, with a year-on-year change of -60.92.

What is the Return on Assets (ROA) of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -29.18, with a year-on-year change of -59.41.

What is the operating profit of Design Therapeutics Inc?

According to Design Therapeutics Inc's FY2025 earnings report, its operating profit was -79.47M, with a year-on-year change of -27.39.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.